Owner PHARMACIA ITALIA SPA

Inventors MOLL, Juergen; KNAPP, Stefan; DALVIT, Claudio; TROSSET, JeanYves; SUNDSTROM, Michael; MANTEGANI, Sergio

Pub. Number AU-A-2002333233

PCT Number PCT/EP02/07536

PCT Pub. Number WO2003/006447

Priority 01202626.6 09.07.01 EP

Filing date 3 July 2002

Wipo publication date 29 January 2003

C07D 307/52 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/28 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 271/113 Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 261/14 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 261/08 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 277/32 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/84 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/06 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 403/06 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 407/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 417/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 413/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

G01N 033/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 031/341 - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 031/381 - having five-membered rings

A61K 031/404

A61K 031/473 - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

C07D 333/22 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 307/66 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/68 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/38 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom